1. $amrn My point was that every time this POS slips a bit, the same guys come and pump... It gets just as old as bashers.. #goodforgoose

  2. $AMRN Should see a nice push up, a nice push down. Where we close our trades nobody knows. Keep the faith $6.84

  3. @studythosestocks $AMRN Epanova is inferior crap product.AZN share holders should sue management 4 wasting money on garbage pharma companies

  4. @JediInvestor Most likely to come PM. That s the usual routine with items like that. $AMRN

  5. $AMRN ? for those that have been around a long time. Do you expect a halt before the combo PR? How have they done it in the past?

  6. @studythosestocks $AMRN Vascepa is much better at lowering apo CIII compared to Epanova.

  7. $amrn just a reminder that good it lowers ApoC but LDL amounts and particle size are more import than actual LDL count. Inferior prod.

  8. $amrn Epanova Lowers Apolipoprotein C-III and Increases LDL-Particle Size in Statin-Treated Patients With Mild Hypertriglyceridemia cont

  9. $AMRN Partners, longer road to 20s...no worries, it just take time. Even if it drops to low 6, more buyers around th corner

  10. Combo happens, its all good $AMRN partherrs

  11. but I still say its possible $AMRN will not get NCE but theIr BP aquierer will get it for V. Everyone yelled no b/o w/o NCE. Hence limbo

  12. $AMRN hands doesn t mean that it will be a Block Buster. If your timeline is correct and AMRN has 18 months, with A and combo.. no contest

  13. $AMRN @shandal you were the one to mention this: http://y.ahoo.it/3K9ugF4a Which is very nice reading. Thus, just because Omertha is in AZN s

  14. it s not that $AMRN needs more. They have accomplished everything they could so far on time or ahead of schedule more coming. Will correctup

  15. let alone what $AMRN has coming. There is something else at work that many dont want to believe. Bitnits not that they need more

  16. many other biotechs would be quadruple this pps on half of what $AMRN has now let alone Cing

  17. you guys still keep trying to look for a reason the pps is this low, they need this that or the other. Wrong just accept $AMRN manipulation

  18. crestor/epano combo drug likely needs an outcomes study to be 50% enrolled like $AMRN, so that is years away//boom softbash debunked again

  19. I would be interested in seeing how $OMTH tech and $AMRN tech would work in a pill. 96% pure free fatty acid EPA would be interesting.

  20. $AMRN Come on Joe time to pull out the show stopper.

  21. $amrn so tnite my fiancé said she wants to short AMRN as she knows I m long and strong, she read that aweful seeking alpha article

  22. @shandal $AMRN Their combo drug likely needs an outcomes study to be 50% enrolled like AMRN, so that is years away.

  23. $AMRN Regardless though, Epanova is in the hands of AZN who also has Crestor so they could turn it into a big combo/drug.. Still competition

  24. @shandal $AMRN Omertha/AZN s DHA/EPA omega-3 is crap compared 2 Vascepa,96%pure EPA,it isnt competition for any Dr.who knows TG s/CV health.

  25. $AMRN Still not sure how Epanova will handle the atrial fibrillation warning and the LDL-C raising.